Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kabra Drugs Ltd is seeking shareholder approval via postal ballot for two special resolutions: (1) change of company name from 'Kabra Drugs Limited' to 'Aanjaay Industries Limited', and (2) major expansion of business objects in the Memorandum of Association to enter entirely new sectors. The new business lines include drones and defence equipment, electric vehicle components, renewable energy/solar power, steel products, healthcare/hospitals, medical training, hospitality, dairy products, agro farms, and artificial intelligence technology. The voting period runs from May 12, 2026 to June 10, 2026, with results to be declared by June 12, 2026. The company has already obtained ROC approval for the new name 'AANJAAY INDUSTRIES LIMITED'.
This represents a fundamental transformation of the company from a drugs/pharmaceutical business into a diversified conglomerate spanning multiple sectors. If approved, shareholders should expect significant changes in company operations, risk profile, and business strategy. The name change and broad diversification may be positive for the stock if the new ventures succeed, but also increases uncertainty given the wide range of unrelated businesses being entered.